Company data
Lyell Immunopharma, Inc. employees and revenue per employee
LYEL · Biotechnology · $352M market cap
Lyell Immunopharma, Inc. had 161 employees at the end of fiscal Dec 2025, down 46.3% from a year earlier. Revenue for the year was $36,000, down 41.0% from a year earlier, or $224 per employee. Revenue fell, and headcount fell or held flat with it.
Employees
161
-46.3% YoY
Revenue
$36,000
-41.0% YoY
Revenue / employee
$224
Peer median $457K
Rank in industry
109 of 110
Biotechnology
Open roles
5
31 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 161 | $36,000 | $224 | -46.3% | -41.0% |
| Dec 2024 | 300 | $61,000 | $203 | +33.9% | -53.1% |
| Dec 2023 | 224 | $130,000 | $1K | -18.2% | -99.8% |
| Dec 2022 | 274 | $84.7M | $309K | +25.1% | +695.1% |
| Dec 2021 | 219 | $10.7M | $49K | — | — |
Open roles on its job board: 5 (31 per 1,000 staff, against its latest annual headcount), as of 2026-11-16. Tracked since 2026-11-09. No 90 day change yet.
Lyell Immunopharma, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
| AVTX Avalo Therapeutics, Inc. | 33 | $59,000 | $2K | Hiring into decline |
| LYEL Lyell Immunopharma, Inc. | 161 | $36,000 | $224 | Contracting |
Questions about Lyell Immunopharma, Inc.
- How many employees does Lyell Immunopharma, Inc. have?
- Lyell Immunopharma, Inc. reported 161 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 12, 2026. That is down 46.3% from a year earlier.
- What is Lyell Immunopharma, Inc.'s revenue per employee?
- Lyell Immunopharma, Inc. brought in $36,000 of revenue in fiscal Dec 2025, which is $224 per employee. That ranks 109 of 110 companies we track in Biotechnology, where the median is $457K.
- Is Lyell Immunopharma, Inc. hiring?
- Lyell Immunopharma, Inc.'s public job board listed 5 open roles on November 16, 2026, about 31 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare LYEL with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Lyell Immunopharma, Inc.'s annual reports (Form 10-K), latest filed March 12, 2026. This is data, not a recommendation to buy or sell LYEL.